Some outcomes, like reduced risk of cardiovascular disease and increased chance of nausea, were expected. But others took ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

specifically in reducing risk of cognitive decline. It is becoming clear that the benefits of these medications go beyond weight loss and diabetes control. And, of course, safety is important as ...

A study shows that patients with obesity and fatty liver-related cirrhosis who had bariatric (weight-loss) surgery significantly lowered their future risk of ... Obesity and diabetes are the ...

The Food and Drug Administration’s approval of Ozempic in 2021 for weight loss treatment ushered in a new era for the class ...

Weight-loss drugs such ... such as lowering the risk of stroke and dementia. Researchers used US Department of Veterans Affairs data to find people with diabetes who used drugs containing GLP ...

Popular GLP-1 medications approved for weight loss ... risk of developing gastroparesis compared with people who were using other types of medications to lower their blood sugar. But having ...

G LP-1 weight-loss drugs are as popular as ever. A Sept. 2024 poll found that roughly 12 percent of U.S. adults have used GLP ...

A class of drugs designed to fight diabetes and weight loss can help with a host of other problems, but also carry some side ...

Doctors say new research has found a link between weight-loss drugs and cancer, putting users at 'significantly higher risk' of the disease. The injections were originally made to tackle diabetes ...

Sold under brand names such as Ozempic and Wegovy, weight loss injections are “skyrocketing” in popularity, with one in eight people in the US using the drugs to treat heart disease, type 2 diabetes ...